dual a2a/a2b antagonists
dual a2a/a2b antagonists: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| REBUS HOLDINGS, INC. (NSPX) | Preclinical |
Get deeper analysis on dual a2a/a2b antagonists
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis